Company · CIK 2023658

# Bicara Therapeutics Inc.

| CIK | [2023658](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002023658) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | BCAX (Nasdaq) |
| First annual or quarterly report | 2024-11-12 |

## Offerings

 2 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-290707 | Shelf Effective | 2025-10-03 | 2026-02-26 | 5 |
| 333-281722 | IPO Final prospectus | 2024-08-22 | 2024-09-13 | 6 |

## Filings

 12

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-02-26 | [424B5](https://www.sec.gov/Archives/edgar/data/2023658/000119312526072875/0001193125-26-072875-index.htm) Shelf takedown | 333-290707 | 0001193125-26-072875 |
| 2026-02-24 | [424B5](https://www.sec.gov/Archives/edgar/data/2023658/000119312526067160/0001193125-26-067160-index.htm) Shelf takedown | 333-290707 | 0001193125-26-067160 |
| 2025-11-26 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2023658/999999999525003395/9999999995-25-003395-index.htm) Declared effective | 333-290707 | 9999999995-25-003395 |
| 2025-11-26 | [424B5](https://www.sec.gov/Archives/edgar/data/2023658/000119312525300510/0001193125-25-300510-index.htm) Shelf takedown | 333-290707 | 0001193125-25-300510 |
| 2025-10-03 | [S-3](https://www.sec.gov/Archives/edgar/data/2023658/000119312525230307/0001193125-25-230307-index.htm) Shelf registered | 333-290707 | 0001193125-25-230307 |
| 2024-09-13 | [424B4](https://www.sec.gov/Archives/edgar/data/2023658/000119312524218862/0001193125-24-218862-index.htm) Final prospectus | 333-281722 | 0001193125-24-218862 |
| 2024-09-12 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2023658/999999999524002816/9999999995-24-002816-index.htm) Declared effective | 333-281722 | 9999999995-24-002816 |
| 2024-09-11 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2023658/000119312524217265/0001193125-24-217265-index.htm) Amendment | 333-281722 | 0001193125-24-217265 |
| 2024-09-06 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2023658/000119312524214674/0001193125-24-214674-index.htm) Amendment | 333-281722 | 0001193125-24-214674 |
| 2024-09-03 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2023658/000119312524211537/0001193125-24-211537-index.htm) Amendment | 333-281722 | 0001193125-24-211537 |
| 2024-08-22 | [S-1](https://www.sec.gov/Archives/edgar/data/2023658/000119312524205393/0001193125-24-205393-index.htm) Registration filed | 333-281722 | 0001193125-24-205393 |
| 2024-06-10 | [DRS](https://www.sec.gov/Archives/edgar/data/2023658/000095012324006172/0000950123-24-006172-index.htm) Draft made public | 377-07267 | 0000950123-24-006172 |

[All filings of this company](https://equitycapital.markets/filings?cik=2023658) · [CSV](https://equitycapital.markets/filings.csv?cik=2023658)

---
Source page: https://equitycapital.markets/company/2023658 · Data: U.S. SEC EDGAR · CC BY 4.0